The main purpose of these studies will be to analyze in detail the regions of the growth hormone receptor (GHR) and the JAK2 kinase that are activated in response to growth hormone binding, to identify signaling molecules that bind to these sequences, and to attempt to determine which signalling pathways are activated by these signalling molecules. The grant is divided into five specific aims. 1. Mass spectrometroscopic analyses of the proteolytic cleavage products of the GH receptor will be used in combination with phosphopeptide mapping and mutagenesis of the GHR to determine which of the tyrosines in GHR are phosphorylated. 2. The principal investigator will utilize the same methodology as in specific aim 1 to gain insight into which tyrosines within JAK2 are phosphorylated in response to GH. 3. The investigator will examine which tyrosines and/or regions of GHR in JAK2 are required for the binding of specific signalling molecules and the activation of discrete signalling pathways. The initial emphasis will be given to the signalling molecules STAT, SHC, IRS-1 and IRS-2. 4. The investigator will determine whether there are any cellular actions of GH that are independent of JAK2. 5. Experiments using available antibodies as well as the yeast 2 hybrid system will attempt to identify previously undiscovered signalling molecules that interact with GHR or JAK2. An alternative approach will be to screen a lambda expression library with phosphorylated peptides derived from GHR or JAK2 to identify such proteins.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK034171-16
Application #
6176347
Study Section
Endocrinology Study Section (END)
Program Officer
Blondel, Olivier
Project Start
1984-08-01
Project End
2001-06-30
Budget Start
2000-07-01
Budget End
2001-06-30
Support Year
16
Fiscal Year
2000
Total Cost
$255,781
Indirect Cost
Name
University of Michigan Ann Arbor
Department
Physiology
Type
Schools of Medicine
DUNS #
791277940
City
Ann Arbor
State
MI
Country
United States
Zip Code
48109
O'Leary, Erin E; Mazurkiewicz-Muñoz, Anna M; Argetsinger, Lawrence S et al. (2013) Identification of steroid-sensitive gene-1/Ccdc80 as a JAK2-binding protein. Mol Endocrinol 27:619-34
Ray, Bridgette N; Kweon, Hye Kyong; Argetsinger, Lawrence S et al. (2012) Research resource: identification of novel growth hormone-regulated phosphorylation sites by quantitative phosphoproteomics. Mol Endocrinol 26:1056-73
Maures, Travis J; Su, Hsiao-Wen; Argetsinger, Lawrence S et al. (2011) Phosphorylation controls a dual-function polybasic nuclear localization sequence in the adapter protein SH2B1? to regulate its cellular function and distribution. J Cell Sci 124:1542-52
Cui, Tracy X; Lin, Grace; LaPensee, Christopher R et al. (2011) C/EBP? mediates growth hormone-regulated expression of multiple target genes. Mol Endocrinol 25:681-93
Argetsinger, Lawrence S; Stuckey, Jeanne A; Robertson, Scott A et al. (2010) Tyrosines 868, 966, and 972 in the kinase domain of JAK2 are autophosphorylated and required for maximal JAK2 kinase activity. Mol Endocrinol 24:1062-76
Robertson, Scott A; Koleva, Rositsa I; Argetsinger, Lawrence S et al. (2009) Regulation of Jak2 function by phosphorylation of Tyr317 and Tyr637 during cytokine signaling. Mol Cell Biol 29:3367-78
Thompson, Brian R; Mazurkiewicz-Muñoz, Anna M; Suttles, Jill et al. (2009) Interaction of adipocyte fatty acid-binding protein (AFABP) and JAK2: AFABP/aP2 as a regulator of JAK2 signaling. J Biol Chem 284:13473-80
Jin, Hui; Lanning, Nathan J; Carter-Su, Christin (2008) JAK2, but not Src family kinases, is required for STAT, ERK, and Akt signaling in response to growth hormone in preadipocytes and hepatoma cells. Mol Endocrinol 22:1825-41
Li, Zhiqin; Zhou, Yingjiang; Carter-Su, Christin et al. (2007) SH2B1 enhances leptin signaling by both Janus kinase 2 Tyr813 phosphorylation-dependent and -independent mechanisms. Mol Endocrinol 21:2270-81
Kurzer, Jason H; Saharinen, Pipsa; Silvennoinen, Olli et al. (2006) Binding of SH2-B family members within a potential negative regulatory region maintains JAK2 in an active state. Mol Cell Biol 26:6381-94

Showing the most recent 10 out of 63 publications